—
C+
C+ The full Closelooknet — membership. Open the C+ overview

IDEXX Laboratories Inc (IDXX) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for IDXX, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-10-12

DayWeekMonth3 months
IDXX+1.1%−0.6%+3.8%−3.1%
Surgical, Med Devices & Animal Health+1.5%+1.5%+7.2%—
HALO Growth 100−0.2%−0.9%−2.9%—

Against the index: 0.3 pts ahead on the week, 6.7 pts ahead on the month; against its Surgical, Med Devices & Animal Health sleeve 3.4 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 57/100 · S&P 500 fund at 71, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-09
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +5.0% over 20 sessions. Factor regime → 2026-10-12
  • Sector × region Health care in US: +2.8% week · +3.5% month · +6.2% quarter · +17.8% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-11
  • Sovereign pressure Index 0.04 · down 0.71 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-09
How it trades on rate days beta 0.68 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How IDXX has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.68 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), IDEXX Laboratories Inc moved 0.68% on average · correlation 0.20 · higher than 68% of US names
  • Beta, last 3 months 0.49 about the same as over the year
  • On the 10 worst bond days −1.32% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.65% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against IDXX on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — IDEXX Laboratories Inc

IDXX in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
IDEXX makes diagnostic instruments and test kits for veterinary clinics, covering blood, urine and companion-animal disease screening. It also sells water-testing kits that detect bacteria such as E. coli, and diagnostic tools for livestock, poultry and dairy operations. Vets and labs buy its analysers, software and consumables as recurring supplies rather than one-off purchases.
Where it sits in the stack
IDEXX carries no seat in our Rubin index, so it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve — a group built around regulated, multi-decade compounders in surgical and diagnostic equipment.
Who it is priced against
Closelooknet's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, Globus Medical, Sonova and Sartorius, names chosen for similar regulated moats in surgery, sensors and animal health; the market also names Zoetis as a comparable animal-health company.
Why Closelooknet tracks it
IDEXX sits in the HALO Growth 100 and the Nasdaq-100. It carries a Closelooknet score, with quality its strongest module and momentum its weakest.
What the diary watches
The diary watches whether the gap between IDEXX's strong quality reading and its weak momentum reading narrows as the shares move further from recent highs.

IDEXX Laboratories Inc (IDXX) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 56/100 composite (momentum 28, quality 85, valuation 24) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by KeyBanc, 2026-10-12

The Street on this name

Analyst actions and the latest print for IDXX from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation KeyBanc — at Sector Weight Initiated to Sector Weight 2026-10-12

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months · buybacks 1.22 bn USD in FY2025

Dividends and capital return

What IDXX pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 1.22 bn USD 3.0% of today's market value
  • Share count −2.9% in FY2025 60 m USD of stock-based compensation in the year
  • Capital returned 1.22 bn USD · 116% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-13

Quick answers

What is IDEXX Laboratories Inc (IDXX)?

IDEXX Laboratories Inc trades as IDXX on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-13.

Is IDXX in a Closelooknet index?

Yes — IDEXX Laboratories Inc is a constituent of HALO Growth 100, as of 2026-10-13.

What is IDEXX Laboratories Inc's Closelooknet composite score?

56 out of 100, with momentum 28, quality 85 and valuation 24 sub-scores, as of 2026-10-13. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does IDXX trade against its moving averages?

Resizing — 32.7% off its high: 32.7% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip. As of 2026-10-09 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is IDXX doing against its Closelooknet index?

Over the past month IDEXX Laboratories Inc is +3.8% against −2.9% for the HALO Growth 100 — 6.7 points ahead of its index, as of 2026-10-12. Its Surgical, Med Devices & Animal Health sleeve is +7.2% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does IDEXX Laboratories Inc compare with its peers?

Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), IDEXX Laboratories Inc (IDXX) sits 32.7% below its 52-week high, 4.0% below its 50-day average; DexCom Inc (DXCM) is 9.2% below, Globus Medical (GMED) is 26.4% below, Intuitive Surgical Inc (ISRG) is 29.8% below. Put any of them next to IDXX in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does IDEXX Laboratories Inc trade when bond yields rise?

Over the past year IDEXX Laboratories Inc had a beta of 0.68 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 68% of US names. On the 10 sessions in which long bonds fell most it moved −1.32% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does IDEXX Laboratories Inc do?

IDEXX makes diagnostic instruments and test kits for veterinary clinics, covering blood, urine and companion-animal disease screening. It also sells water-testing kits that detect bacteria such as E. coli, and diagnostic tools for livestock, poultry and dairy operations. Vets and labs buy its analysers, software and consumables as recurring supplies rather than one-off purchases. Closelooknet's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, Globus Medical, Sonova and Sartorius, names chosen for similar regulated moats in surgery, sensors and animal health; the market also names Zoetis as a comparable animal-health company.

Where does IDEXX Laboratories Inc sit in the AI build-out?

IDEXX carries no seat in our Rubin index, so it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve — a group built around regulated, multi-decade compounders in surgical and diagnostic equipment. IDEXX sits in the HALO Growth 100 and the Nasdaq-100. It carries a Closelooknet score, with quality its strongest module and momentum its weakest.

Does IDEXX Laboratories Inc pay a dividend?

No cash distribution shows in IDEXX Laboratories Inc’s price series over the last three years. In fiscal 2025 the company bought back 1.22 bn USD of its own shares, 116% of that year’s free cash flow. The share count fell 2.9% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on IDEXX Laboratories Inc recently?

The most recent analyst action on IDEXX Laboratories Inc on the Closelooknet wire is a initiation by KeyBanc on 2026-10-12 (at Sector Weight). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for IDXX, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.